Last reviewed · How we verify
Intestinal microbiota capsules
Intestinal microbiota capsules is a Small molecule drug developed by First Affiliated Hospital of Ningbo University. It is currently FDA-approved.
Intestinal microbiota capsules, specifically a multi-strain oral probiotic known as CDS22-formula, have been studied in clinical trials for various conditions including endometriosis, bacterial vaginosis, menopause, and obesity. The mechanism of action of these capsules is related to proteins, specifically vasoactive intestinal peptide (VIP), which is involved in various physiological processes.
At a glance
| Generic name | Intestinal microbiota capsules |
|---|---|
| Sponsor | First Affiliated Hospital of Ningbo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma (PHASE2)
- Effect of Oral Microbiota on MDRO Decolonization (PHASE1, PHASE2)
- Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure (PHASE1)
- CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease (EARLY_PHASE1)
- Clinical Trial of Lactiplantibacillus Plantarum Dad-13 on Gut Microbiota Profile and Performance in Adolescent Athletes (NA)
- Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC (PHASE2)
- Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer (EARLY_PHASE1)
- Red Yeast Rice for Primary Prevention of Hypercholesterolemia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intestinal microbiota capsules CI brief — competitive landscape report
- Intestinal microbiota capsules updates RSS · CI watch RSS
- First Affiliated Hospital of Ningbo University portfolio CI
Frequently asked questions about Intestinal microbiota capsules
What is Intestinal microbiota capsules?
Who makes Intestinal microbiota capsules?
What development phase is Intestinal microbiota capsules in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing